Business Standard
Wednesday, May 30, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

IOL Chemicals to hire 400 more this year
BS Reporter / New Delhi/ Jalandhar Apr 10, 2009, 00:53 IST

Ludhiana-based IOL Chemicals and Pharmaceuticals Limited (IOLCP) has said that it will add 400 more employees to its existing workforce of 900 by this year end. Despite the global economic slowdown, this is a big stride by IOLCP towards gearing itself for global opportunities in the pharmaceutical industry, company sources said.

The new workforce will primarily take care of the company’s proposed expansion with an outlay of Rs 216 crore, which would include capacity expansion for its various product lines, forward integration in the chemical and backward integration in the pharmaceutical divisions to produce raw materials for its flagship product Ibuprofen, besides increasing its cogeneration of power.

 
“We have received certifications for exporting Ibuprofen to newer international markets. We are working at an enormous pace to increase our manufacturing capacities so as to meet the burgeoning demand and the new workforce will play an instrumental role in the execution of our plans,” IOLCP chairman and managing director Varinder Gupta said,

IOCP has recently enhanced its Ibuprofen production capacity from 1,800 tonne to 3,600 tonne a year. The company aims to further expand the capacity to 6,000 tonne, Gupta said, adding “With the forward integration in the chemical division, we intend to produce 4,800 tonne of acetyl chloride and 6,600 tonne of MCA, which are raw materials for Ibuprofen.”

Gupta said the company, which currently has a 4 Mw cogeneration plant, was constructing a new 13 Mw captive plant, which is expected to be commissioned by the end of 2010.

IOLCP is also diversifying into the manufacture of anti-ulcerants and proton pump inhibitors (PPIs) like Rabiprazole with a proposed investment of Rs 80 crore.

It expects revenues to the tune of Rs 250 crore from its PPIs business.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end lower ahead of May F&O expiry
- HDIL Q4 net up 70%, revenue rises by 13%
- Keshub to retire as Chairman of M&M, Anand to take over
- GMR Infra posts Rs 366 cr loss in Q4
- GAIL profit dips 38% in Jan-Mar
  Read Business news in 
- India's no. 1 Property Site. Click here to know more
- "Discover The Power of One"
- Journey on, We are by Your Side. Click here to know more
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- Learn How One City is Running on FOOD SCRAPS.
- 1 billion in saving for Unilever without any tangles.
- A Brand New Server at a Price That Fits Your Budget. Click here
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
- 2 Lac Apartments, 1 Lac House / Plots. Click here
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- SBI to rework structure in circles
- Foreign investor norms eased to accelerate capital inflows
- JLR helps Tata Motors log over two-fold rise in net
- KBC 6 gets record registrations
- After SC rebuke, N D Tiwari gives blood sample
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us